Genetic interactions between MTHFR (C677T), methionine synthase (A2756G, C2758G) variants with vitamin B12 and folic acid determine susceptibility to premature coronary artery disease in Indian population

Journal of Cardiovascular Disease Research

Volumn 2, Issue 3, 2011, Pages 156-163

  Ravi Kanth, V V ^a   Golla, Jaya Prakash ^a,e   Sastry, B K S ^b   Naik, Sudhir ^c   Kabra, Nitin ^d   Sujatha, Madireddi ^a  

^a OSMANIA UNIVERSITY   (India)

^b CARE HOSPITAL   (India)

^c APOLLO HOSPITAL   (India)

^d Gandhi Hospital   (India)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Hyperhomocysteinemia; methionine synthase; methylenetetrahydrofolate reductase; polymorphisms; premature coronary artery disease

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE SYNTHASE;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; COFFEE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG SENSITIVITY; FOOD INTAKE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; INDIAN; MAJOR CLINICAL STUDY; MARKER GENE; MS GENE; MTHFR GENE; MUTATIONAL ANALYSIS; POPULATION RESEARCH; PREMATURE CORONARY ARTERY DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; VITAMIN BLOOD LEVEL;

EID: 80054034531     PISSN: 09753583     EISSN: 09762833     Source Type: Journal    
DOI: 10.4103/0975-3583.85262     Document Type: Article

References (33)

1. Wild S, McKeigue P. Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92. BMJ 1997;314:705-10. (Pubitemid 27113071)
2. Chambers JC, Kooner JS. Homocysteine: A novel risk factor for coronary heart disease in UK Indian Asians. Heart 2001;86:121-2. (Pubitemid 32983465)
3. Gauthier GM, Keevil JG, McBride PE. The association of homocysteine and coronary artery disease. Clin Cardiol 2003;26:563-8. (Pubitemid 37486835)
4. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999;99:178-82. (Pubitemid 29035977)
5. Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: From basic science to clinical evidence. Thromb Haemost 2005;94:907-15. (Pubitemid 41645928)
6. Nygård O, Vollset SE, Refsum H, Brattström L, Ueland PM. Total homocysteine and cardiovascular disease. J Intern Med 1999;246:425-54. (Pubitemid 29529786)
7. Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Eng J Med 1997;337;230-6. (Pubitemid 27310438)
8. Jacobsen DW, Catanescu O, Dibello PM, Barbato JC. Molecular targeting by homocysteine: A mechanism for vascular pathogenesis. Clin Chem Lab Med 2005:43:10;1076-83. (Pubitemid 41581964)
9. Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, et al. Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 1998;9:652-6. (Pubitemid 28355328)
10. Rozen R. Genetic predisposition to hyperhomocysteinemia: Deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 1997;78:523-6. (Pubitemid 27289296)
11. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: A common methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
12. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet 1991;48:536-45. (Pubitemid 21903052)
13. Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J, Shane B. Human methionine synthase cDNA cloning, gene localization and expression. J Biol Chem 1997;272;3628-34.
14. Dietz HC, Pyeritz RE. Molecular Biology- To the Heart of the Matter. N Engl J Med 1994;330:930-2.
15. Ueland PM, Refsum H, Beresford SA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000;72:324-32. (Pubitemid 30623491)
16. Födinger M, Hörl WH, Sunder-Plassmann G. Molecualar biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol 2000;13:20-33.
17. Isotalo PA, Wells GA, Donnelly JG. Neonatal and Fetal methylenetetrahydrofolate reductase genetic polymorphisms: An examination of C677T and A1298C mutations. Am J Hum Genet 2000;67:986-90.
18. Muñoz-Moran E, Dieguez-Lucena JL, Fernandez-Arcas N, Peran- Mesa S, Reyes-Engel A. Genetic selection and folate intake during pregnancy. Lancet 1998;352:1120-1. (Pubitemid 28448525)
19. Krishnaswamy K, Lakshmi AV. Role of nutritional supplementation in reducing the levels of homocysteine. J Assoc Physicians India 2002;50:36-42.
20. Mathews JH, Wood JK. Megaloblastic anaemia in vegetarian Asians. Clin Lab Haematol 1984;6;1-7. (Pubitemid 14107986)
21. Dawson DW, Waters HM. Malnutrition, folate and cobalamine deficiency. Br J Biomed Sci 1994;51;221-7.
22. Vasisht S, Gulati R, Narang R, Srivastava N, Srivastava LM, Manchanda SC, et al. Polymorphism (C677T) in the 5, 10-methylenetetrahydrofolate reductase (MTHFR) gene: A preliminary study on North Indian men. Indian J Clin Biochem 2002;1:99-107.
23. Radha Rama Devi V, Govindaiah GR, Naushad SM. Prevalence of methylene tetrahydrofolate reductase polymorphism in South Indian population. Curr Sci 2004;86:440-3. (Pubitemid 39160285)
24. Chambers JC, Ireland H, Thompson E, Reilly P, Obeid OA, Refsum H, et al. Methylenetetrahydrofolate reductase 677 C→T mutation and coronary heart disease risk in UK South Asians. Arterioscler Thromb Vasc Biol 2000;20:2448-52.
25. Rothenbacher D, Fischer HG, Hoffmeister A, Hoffmann MM, März W, Bode G, et al. Homocysteine and methylenetetrahydrofolate reductase genotype: Association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters. Atherosclerosis 2002;162:193-200. (Pubitemid 34327358)
26. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, et al. Human methionine synthase: CDNA cloning and identification of mutations in patients of the cblG complementation group of folate / cobalmin disorders. Human Mol Genet 1996;5;1867-74. (Pubitemid 26413628)
27. Biselli PM, Guerzoni AR, de Godoy MF, Eberlin MN, Haddad R, Carvalho VM, et al. Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease. J Thromb Thrombolysis 2010;29:32-40.
28. La Vecchia C, Decarli A, Pagano R. Vegetable consumption and risk of chronic disease. Epidemiology 1998;9:208-10. (Pubitemid 28157622)
29. Ravi Kanth VV, Prakash GJ, Naik S, Kabra N, Sujatha M. Premature coronary artery disease: Role of free radical nitric oxide. Indian Heart J 2008;60:45-9.
30. Nygård O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. Am J Clin Nutr 1998;67:263-70. (Pubitemid 28076718)
31. Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Rodahl K. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. N Engl J Med 1993;328:533-7. (Pubitemid 23053829)
32. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 1990;132:612-28. (Pubitemid 20344530)
33. Abraham R, John MJ, Calton R, Dhanoa J. Raised serum homocysteine levels in patients of coronary artery disease and the effect of vitamin B12 and folate on its concentration. Indian J Biochem 2006;21;95-100.